E Thomas Corcoran bought $318K of Phibro Animal Health (PAHC)
Executed May 29, disclosed Jun 2, 4 days later.
Over the 21 trading sessions from the disclosed entry session (Jun 2), the stock returned +8.1% (delay-adjusted); from the execution session (May 29), +0.6%. Derived: entry at the session's open, exit at the close 20 sessions later.
E Thomas Corcoran (Director) filed 1 Form 4 report in the trailing twelve months (1 purchase, 0 sales), most often in Phibro Animal Health Corporation (PAHC). Across 1 priced purchase filing, the average 21-session return was +0.6% from execution and +8.1% from disclosure (delay-adjusted; derived). The largest single filing was $318K of PAHC (10,000 sh × $31.77, as filed), executed May 29.
Healthcare · Phibro Animal Health Corporation operates as an animal health and mineral nutrition company in the United States, Latin America and Canada,…
More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→5,000 sh × $22.10
Exec Feb 24 2025
Filed Feb 26 2025 · 5:30 PM ET